Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 21 for PAZOPANIB
  1. Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... the intestines, heart problems, and slow wound healing. Pazopanib (Votrient ® ) Pazopanib is another drug that blocks several tyrosine kinases ...
  3. ... in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), axitinib (Inlyta ® ), ... Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other types of ...
  4. List of Confused Drug Names (Institute for Safe Medication Practices) - PDF  
    ... Pavulon Peptavlon Paxil Doxil Paxil Taxol Paxil Plavix pazopanib ponatinib PEME trexed PRALA trexate penicillin penicillamine penicillamine ... polyvalent vaccinepneumococcal 7-valent vaccine Polycitra Bicitra ponatinib pazopanib potassium acetate sodium acetate PRALA trexate PEME trexed ...
  5. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Kidney cancer: Bevacizumab (Avastin®) , sorafenib (Nexavar®) , sunitinib (Sutent®) , pazopanib (Votrient®) , temsirolimus (Torisel®) , everolimus (Afinitor®) , axitinib (Inlyta®) Leukemia: ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hydrochloride Pamidronate Disodium Panitumumab Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon Alfa-2b PEG-Intron (Peginterferon ...
  7. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is approved for ... for both kidney cancer and neuroendocrine tumors, and pazopanib for kidney cancer. Researchers are exploring the use ...
  8. ... being studied in clinical trials, including the following: Pazopanib is a tyrosine kinase inhibitor being studied in ...
  9. ... drugs are also being looked at, as well. Pazopanib (Votrient ® ) is a targeted therapy drug that, like ...
  10. ... or proteins, such as sorafenib (Nexavar), bevacizumab (Avastin), pazopanib (Votrient), and everolimus (Afinitor), are now being studied ...
previous · 1 · 2 · 3 · next